This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.
Company Profile:
C4 Therapeutics, Inc.
Market Cap (USD):
$311.0 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Avacta Group plc
Market Cap (USD):
$308.0 M
Country:
United Kingdom
Sector:
UK Healthcare
Industry:
UK Biotechnology
Company Profile:
Taiwan Liposome Company, Ltd.
Market Cap (USD):
$302.9 M
(Sept. 1, 2021)
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
Amarin Corporation plc
Market Cap (USD):
$302.6 M
Country:
Ireland
Sector:
Irish Healthcare
Industry:
Irish Biotechnology
Company Profile:
Xiangxue Pharmaceutical Co.,Ltd.
Market Cap (USD):
$300.2 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Oyster Point Pharma, Inc.
Market Cap (USD):
$299.9 M
(Dec. 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Bioventix plc
Market Cap (USD):
$299.7 M
Country:
United Kingdom
Sector:
UK Healthcare
Industry:
UK Biotechnology
Company Profile:
XOMA Corporation
Market Cap (USD):
$298.3 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Poseida Therapeutics, Inc.
Market Cap (USD):
$293.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Foghorn Therapeutics Inc.
Market Cap (USD):
$293.2 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Alphamab Oncology
Market Cap (USD):
$290.4 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Ryvu Therapeutics SA
Market Cap (USD):
$290.2 M
Country:
Poland
Sector:
Polish Healthcare
Industry:
Polish Biotechnology
Company Profile:
Nautilus Biotechnology, Inc.
Market Cap (USD):
$288.1 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Cerecor Inc.
Market Cap (USD):
$285.0 M
(June 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
ALX Oncology Holdings Inc.
Market Cap (USD):
$283.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Enanta Pharmaceuticals, Inc.
Market Cap (USD):
$283.6 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Shenzhen Bioeasy Biotechnology Co. Ltd
Market Cap (USD):
$280.7 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Chempartner Pharmatech Co. Ltd
Market Cap (USD):
$279.2 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Revance Therapeutics, Inc.
Market Cap (USD):
$278.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Inozyme Pharma, Inc.
Market Cap (USD):
$277.7 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Zhejiang Wecome Pharmaceutical Company Ltd
Market Cap (USD):
$276.4 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Atea Pharmaceuticals, Inc.
Market Cap (USD):
$273.7 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Savior Lifetec Corp
Market Cap (USD):
$270.3 M
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
Immutep Limited
Market Cap (USD):
$266.4 M
Country:
Australia
Sector:
Australian Healthcare
Industry:
Australian Biotechnology
Company Profile:
Panion & Bf Biotech, Inc.
Market Cap (USD):
$264.7 M
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
Imugene Limited
Market Cap (USD):
$264.1 M
Country:
Australia
Sector:
Australian Healthcare
Industry:
Australian Biotechnology
Company Profile:
MacroGenics, Inc.
Market Cap (USD):
$263.1 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
MeiraGTx Holdings plc
Market Cap (USD):
$258.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Zentalis Pharmaceuticals, Inc.
Market Cap (USD):
$257.1 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Chiasma, Inc.
Market Cap (USD):
$253.0 M
(July 1, 2021)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology